| Trial ID: | L7046 |
| Source ID: | NCT01087645
|
| Associated Drug: |
Nn9925 (Oral)
|
| Title: |
A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2|Healthy
|
| Interventions: |
DRUG: NN9925 (oral)|DRUG: NN9925 (i.v.)|DRUG: placebo|DRUG: NN9925 (oral)|DRUG: placebo
|
| Outcome Measures: |
Primary: Number and severity of adverse events (AEs) recorded, from dosing to Day 22 | Secondary: The uptake in blood of oral NN9925, from 0 to 504 hours
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
70
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-03-12
|
| Completion Date: |
2010-09-16
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-28
|
| Locations: |
Novo Nordisk Investigational Site, Nottingham, NG11 6JS, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT01087645
|
